Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years. (Q53188371)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Sustained improvement of health-related quality of life in Crohn's disease patients treated with infliximab and azathioprine for 4 years (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Francesc Casellas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Pilar Niño

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Carmen Pantiga

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Sabino Riestra

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Juan-Ramon Malagelada

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

1395-1400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17567874%20AND%20SRC:MED&resulttype=core&format=json

Quality of life measurement in gastrointestinal and liver disorders

31 December 2019

cites work

1 reference

The quality of life in patients with Crohn's disease

21 January 2018

1 reference

Assessing the quality of life of household members of patients with inflammatory bowel disease: development and validation of a specific questionnaire.

21 January 2018

1 reference

Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study.

21 January 2018

1 reference

Infliximab improves quality of life in patients with Crohn's disease

21 January 2018

1 reference

Quality of Life Improves Within 30 Days of Surgery for Crohn’s Disease

21 January 2018

1 reference

Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease.

21 January 2018

1 reference

Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life

21 January 2018

1 reference

Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.

21 January 2018

1 reference

Remission on thiopurinic immunomodulators normalizes quality of life and psychological status in patients with Crohn's disease.

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years.

21 January 2018

1 reference

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate

21 January 2018

1 reference

A simple index of Crohn's-disease activity

21 January 2018

1 reference

Validation of the spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease.

21 January 2018

1 reference

Relevance of the phenotypic characteristics of Crohn's disease in patient perception of health-related quality of life.

21 January 2018

1 reference

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

21 January 2018

1 reference

Influence of inflammatory bowel disease on different dimensions of quality of life.

21 January 2018

1 reference